| Labatec Pharma SA - Octreotid Labatec 0,05 mg/mL, Solution pour injection | | 63241 | | 01 | | Octreotid Labatec 0,05 mg/mL | | Solution pour injection | | H01CB02 | | Octreotid | | 16.04.2014 | | |
| | Composition | | octreotidum 0.05 mg ut, octreotidi acetas, glycinum, mannitolum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. | | Packungsbestandteile | | Solution pour injection | | | | | | | | Principe actif | Concentr. |
|---|
| Octreotide | 0.05 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Octreotide | 0.05 mg |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum | | Glycine | | Mannitol | | Octreotide Acetate | | Ut |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 1 ampoule(s) à 1 ml | 19.99 | 38.15 | A | LS | Non |
|
|
